Adverse reactions to β-lactam antimicrobials
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Beta-lactam antibiotics are among the most clinically useful antimicrobials used in medicine. Unfortunately, adverse events related to their use remain poorly understood by many clinicians and, in particular, the misdiagnosis of β-lactam allergy and misunderstanding of crossreactivity among members of the β-lactam antibiotics may effectively eliminate a whole class of antimicrobials from use and require the use of broader spectrum agents with less well-established safety profiles. AREAS COVERED: This review describes the range, diagnosis and management of adverse events associated with β-lactam antimicrobials, particularly focusing on recognition, diagnosis and management of true allergy and risk of cross-sensitivity between β-lactam antibiotics. A literature review was undertaken using PubMed, focusing primarily on literature published in the past 10 years relating to β-lactam adverse events and allergy. EXPERT OPINION: Beta-lactams are generally safe drugs and serious adverse events are rare and allergy is overdiagnosed. Accurate diagnosis can usually be achieved through careful history and in some instances skin or in vitro testing is required. Even among individuals with true immediate-type allergy to penicillin, most cephalosporins are readily tolerated and desensitization is usually an option in cases where no alternate antimicrobials are available. Other allergic reactions (Type II, III and IV) are rare and avoidance of the culprit agent is generally recommended. Nonallergic or morbilliform rashes are generally not allergic in nature and should not prompt drug or class avoidance. Other adverse events are frequently dose-related and can be avoided by appropriate dosing and consideration of renal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
Andersohn, F., Konzen, C., & Garbe, E. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00009 · Cited by 479
Sogn, D. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400170105020 · Cited by 337 · cited 1×
“Although the reported rate of suspected penicillin allergy ranges from 1 to 10% [25,26], the true incidence of demonstrable IgE-mediated allergy to penicillin (by skin test) in this population is between 10 and 20% [15,27].”
BackgroundWhite, A. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh050 · Cited by 198
Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis.
Pichichero, M. E., & Casey, J. R. (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2006.10.007 · Cited by 184 · cited 6×
“The results clearly indicated that in the presence of a history of allergy to penicillin or amoxicillin, there was an increased risk of allergy only to cephalothin, cephaloridine and cephalexin (all first-generation agents) while no increased risk of allergy existed for cefprozil, cefpodoxime, ceftazidime and cefuroxi…”
BackgroundResultInfluentialBickford, C. L., & Spencer, A. P. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.10.1389 · Cited by 56 · cited 6×
“The sludging typically resolves after discontinuation of therapy [146].”
BackgroundInfluential
Cited by
Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships
Imani, S., Buscher, H., Marriott, D., Gentili, S., & Sandaradura, I. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx209 · Cited by 320
Macy, E., & Contreras, R. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.062 · Cited by 153
Antibiotic therapy for adults with neurosyphilis
Buitrago-Garcia, D., Martí-Carvajal, A. J., Jimenez, A., Conterno, L. O., & Pardo, R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011399.pub2 · Cited by 30
Metadata
- Authors
- Lagacé-Wiens, P., & Rubinstein, E.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2012-01-06
- Volume
- 11
- Issue
- 3
- Pages
- 381-399
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2019625594
- Cited by
- 101
- References
- 5
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adverse reactions to β-lactam antimicrobials. https://app.cochat.ai/papers/10.1517/14740338.2012.643866
- The paper
- Lagacé-Wiens, P., & Rubinstein, E. (2012). Adverse reactions to β-lactam antimicrobials. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.2012.643866
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.